Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q36205344)
Watch
English
Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
title
Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
main subject
multiple sclerosis
1 reference
based on heuristic
inferred from title
author
Xavier Montalban
series ordinal
6
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
author name string
O Fernández
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
C Oreja-Guevara
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
R Arroyo
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
G Izquierdo
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
J L Pérez
series ordinal
5
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
publication date
1 September 2012
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
published in
Journal of Neurology
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
volume
259
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
issue
9
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
page(s)
1814-1823
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
exact match
https://scigraph.springernature.com/pub.10.1007/s00415-012-6414-9
0 references
cites work
Three years of experience: the Italian registry and safety data update.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
1 October 2017
Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
1 October 2017
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
1 October 2017
Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri) in inflammatory diseases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
1 October 2017
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
1 October 2017
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
1 October 2017
Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
1 October 2017
Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
1 October 2017
An observational study of the effectiveness and safety of natalizumab in the treatment of multiple sclerosis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
22 September 2018
The efficacy of natalizumab in patients with multiple sclerosis according to level of disability: results of an observational study.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
22 September 2018
Swedish natalizumab (Tysabri) multiple sclerosis surveillance study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
22 September 2018
Natalizumab treatment in multiple sclerosis: the experience of S. Andrea MS Centre in Rome.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
22 September 2018
Natalizumab reduces clinical and MRI activity in multiple sclerosis patients with high disease activity: results from a multicenter study in Switzerland.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
22 September 2018
Demographic and clinic characteristics of French patients treated with natalizumab in clinical practice.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
22 September 2018
Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
22 September 2018
Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
22 September 2018
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
22 September 2018
Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
22 September 2018
A controlled trial of natalizumab for relapsing multiple sclerosis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3432776
retrieved
22 September 2018
Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5)
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22289966
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22289966
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1007/S00415-012-6414-9
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
PMC publication ID
3432776
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
PubMed publication ID
22289966
1 reference
stated in
Europe PubMed Central
PMC publication ID
3432776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
ResearchGate publication ID
221791410
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit